Document:

Form of Restricted Share

 Exhibit 10.1 

AMENDED AND RESTATED 

COTT CORPORATION 
 EQUITY
INCENTIVE PLAN 
 RESTRICTED SHARE UNIT AWARD AGREEMENT 

(Performance-Based Vesting) 

1. Performance-Based Share Unit Award – Terms and Conditions. Under and subject to the provisions of the Amended and Restated Cott
Corporation Equity Incentive Plan (the “Plan”) and upon the terms and conditions set forth herein, Cott Corporation (the “Company”) has granted to
                     (the “Grantee”), effective              (the “Date of
Grant”), a Restricted Share Unit Award (the “Award”) of                      performance-based restricted share units (such units, the
“Performance Units”), in respect of services to be provided in          and thereafter. At all times, each Performance Unit shall be equal in value to one common share in the capital of the Company
(each, a “Share”). Such Award is subject to the terms and conditions of this Performance-Based Restricted Share Unit Agreement (the “Agreement”) and the Plan. 

(a) Performance Period. For purposes of this Agreement, the “Performance Period” is the period beginning on
            , which is the first day of the Company’s      fiscal year, and ending on the last day of the Company’s      fiscal year. 

(b) Payout of Award. Provided the Award has not previously been forfeited, as soon as administratively practicable following the
expiration of the Performance Period, but in no event later than the later to occur of (i) sixty (60) days following the expiration of the Performance Period and (ii) the date that audited financial statements are available for the
Company’s      fiscal year, the Company shall issue to the Grantee in a single payment the number of Shares underlying the Performance Units to which the Grantee is entitled pursuant hereto. The Shares issued by the Company
hereunder may at the Company’s option be either (i) evidenced by a certificate registered in the name of the Grantee or his or her designee; or (ii) credited to a book-entry account for the benefit of the Grantee maintained by the
Company’s stock transfer agent or its designee. 
 (c) Satisfaction of Performance Objectives. The payout of the Award shall be
contingent upon the attainment during the Performance Period of the performance objectives set forth in Section 1(e) herein (the “Performance Objectives”). The payout of the Award shall be determined upon the expiration of the
Performance Period in accordance with the Performance Objectives. The final determination of the payout of the Award will be authorized by the Human Resources and Compensation Committee of the Company’s Board of Directors (the
“Committee”). 
 (d) Rights During Performance Period. During the Performance Period, the Grantee shall not have any
rights as a shareholder with respect to the Shares underlying the Performance Units. Upon the expiration of the Performance Period and payout of the Award, the Grantee may exercise voting rights and shall be entitled to receive dividends and other
distributions with respect to the number of Shares to which the Grantee is entitled pursuant hereto. 

  
 1 

 (e) Performance Objectives. Subject to Section 2 of this Agreement, the Performance
Units shall vest and become non-forfeitable as set forth in the chart below based on the Company’s achievement of a specified level of cumulative Pre-Tax Income for the Performance Period: 

 

					
	 Pre-Tax Income
	  	Percentage of Performance Units Vested	 
		
	 125% of Target or greater
	  	 	200	% 
		
	 100% of Target
	  	 	100	% 
		
	 70% of Target
	  	 	40	% 
		
	 Less than 70% of Target
	  	 	0	% 

 The applicable percentage of Performance Units vested will be interpolated on a linear basis between the
levels stated in the chart above, but only to the extent that Pre-Tax Income exceeds 70% of Target. The number of Performance Units that vest based on Performance Objectives will be determined by the Committee following the end of the Performance
Period (the “Final Committee Determination”) and payment of vested Performance Units will be made in the period provided for in Section 1(b) of this Agreement. Any Performance Units that do not vest based on the Performance Objectives
described herein (and which have not previously terminated pursuant to the terms of this Agreement) will automatically terminate as of the Final Committee Determination. Any such determination by the Committee shall be final and binding. 

For purposes of this Section 1(e), the following definitions shall apply: 

“Pre-Tax Income” shall mean, subject to Section 4, earnings before income taxes of the Company for the Performance Period based on the
Company’s audited financial statements for such period.
 “Target” shall mean cumulative Pre-Tax Income in the amount of
$             for the Performance Period. 
 2. Prohibition Against Transfer. Until
the expiration of the Performance Period and payout of the Award, the Award, the Performance Units subject to the Award, and any interest in Shares related thereto, and the rights granted under this Agreement are not transferable or assignable other
than for normal estate settlement purposes. Until the expiration of the Performance Period and payout of the award, the Award, the Performance Units and any interest in Shares related thereto, may not be sold, exchanged, assigned, transferred,
pledged, hypothecated, encumbered or otherwise disposed of, shall not be assignable by operation of law, and shall not be subject to execution, attachment, charge, alienation or similar process. Any attempt to effect any of the foregoing shall be
null and void and without effect. 
 3. Securities Law Requirements. The Company shall not be required to issue Shares pursuant
to the Award, to the extent required, unless and until (a) such Shares have been duly listed upon each stock exchange on which the Common Shares are then registered; and (b) a registration statement under the Securities Act of 1933 with
respect to such Shares is then effective. 

  
 2 

 4. Adjustments. For purposes of calculating Pre-Tax Income, adjustments will be made for
items that are discretely disclosed in either the financial statements, footnotes thereto or Management’s Discussion and Analysis sections of the Company’s quarterly or annual filings with the U.S. Securities and Exchange
Commission. The following are the adjustments to Pre-Tax Income: 
  

	 	a.	The impact of changes to U.S. generally accepted accounting principles (“US GAAP”); 

  

	 	b.	The impact of changes to tax laws or other regulations in any jurisdiction the Company operates in; 

  

	 	c.	The impact of discontinued operations or items that are unusual or infrequently occurring as defined by US GAAP; 

  

	 	d.	All expenses related to capital markets and M&A transactions authorized by the Board of Directors, including professional advisor fees, investment banking fees and gains or losses due to the repurchase of debt or
equity; 

  

	 	e.	Gains or losses resulting from, or expenses incurred for the restructuring of the Company’s legal and tax structure in place at the beginning of the 2010 fiscal period, including gains or losses due to intercompany
loans between the Company’s subsidiaries; and 

  

	 	f.	US GAAP purchase accounting adjustments in connection with the acquisition of DS Services of America Inc. by Crestview Partners and the Company. 

5. Incorporation of Plan Provisions. This Agreement is made pursuant to the Plan, the provisions of which are hereby incorporated
by reference. Capitalized terms not otherwise defined herein shall have the meanings set forth for such terms in the Plan. In the event of a conflict between the terms of this Agreement and the Plan, the terms of the Plan shall govern. 

6. Compliance with Section 409A of the Code. To the extent applicable, it is intended that the Agreement and the Plan comply
with the provisions of Section 409A of the Code, so that the income inclusion provisions of Section 409A(a)(1) of the Code do not apply to the Grantee. The Agreement and the Plan shall be administered and interpreted in a manner consistent
with this intent, and any provision that would cause the Agreement or the Plan to fail to satisfy Section 409A of the Code shall have no force and effect until amended to comply with Section 409A of the Code (which amendment may be
retroactive to the extent permitted by Section 409A of the Code and may be made by the Corporation without the consent of the Grantee). Notwithstanding the foregoing, no particular tax result for the Grantee with respect to any income
recognized by the Grantee in connection with the Agreement is guaranteed, and the Grantee solely shall be responsible for any taxes, penalties or interest imposed on the Grantee in connection with the Agreement. Reference to Section 409A of the
Code will also include any regulations, or any other guidance, promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service. 

  
 3 

 7. Tax Withholding. 

(a) Grantees Other Than UK Grantees. The Grantee shall pay all applicable income and employment taxes (including taxes of any foreign
jurisdiction) which the Company or a Subsidiary is required to withhold at any time with respect to the Units. Such payment shall be made in full, at the Grantee’s election, in cash or check, by withholding from the Grantee’s next normal
payroll check, or by the relinquishment of Shares that otherwise would be issued to the Grantee pursuant to this Agreement. Shares tendered as payment of required withholding shall be valued at the closing price per share of the Company’s
common stock on the date such withholding obligation arises. 
 (b) UK Grantees. By executing this Agreement, the Grantee agrees with
the Company (for itself and on behalf of the Grantee’s employing company (the “Employer”)) that the Company (or, if it is the secondary contributor in respect of the Grantee for the purposes of national insurance contributions, the
Employer) may recover from the Grantee (by deduction or otherwise) an amount equal to any secondary Class 1 contributions payable in respect of the acquisition by the Grantee of any Shares pursuant to this Agreement, together with any income tax and
primary Class 1 contributions due under the Pay As You Earn system in respect of any Shares acquired by the Grantee pursuant to this Agreement and the Grantee hereby agrees to indemnify the Company and the Employer for such amounts. For the
avoidance of doubt, a broker or trustee instructed by the Grantee shall be entitled to retain, out of the aggregate number of Shares issued in the name of the Grantee and to which the Grantee would otherwise be entitled pursuant to this Agreement,
and sell as agent for the Grantee, such number of Shares as in the opinion of the Company or the Employer will realize an amount equivalent to any amount due from the Grantee pursuant to this Section and to pay such proceeds to the Employer to
reimburse it for such amount. 
 8. Employment. The rights and obligations of the Grantee under the terms of his office or employment
with the Employer will not be affected by his participation in the Plan or any right which he may have under this Agreement and this Agreement does not form part of any contract of employment between the Grantee and the Employer. If the
Grantee’s office or employment is terminated for any reason whatsoever (and whether lawful or otherwise) he will not be entitled to claim any compensation for or in respect of any consequent diminution or extinction of his rights or benefits
(actual or prospective) under this Agreement or otherwise in connection with the Plan. 
 9. Beneficiary Designation. The Grantee
may, subject to compliance with all applicable laws, name, from time to time, any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under the Plan is to be paid in the event of the Grantee’s death
before the Grantee receives any or all of such benefit. Each designation will revoke all prior designations by the Grantee, shall be in the form as may be prescribed by the Committee, and will be effective only when filed by the Grantee in writing
with the Committee during his or her lifetime. In the absence of any such designation, benefits remaining unpaid at the Grantee’s death shall be paid to his or her estate. 

10. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Florida and the laws
of the United States applicable therein. 

  
 4 

 11. Severability. The invalidity or unenforceability of any provision of this Agreement
shall not affect the validity or enforceability of any other provision of this Agreement. 
 12. Entire Agreement. 

(a) The Grantee hereby acknowledges that he or she has received, reviewed and accepted the terms and conditions applicable to this Agreement,
and has not been induced to enter into this Agreement or acquire any Performance Units by expectation of employment or continued employment with the Company or any of its subsidiaries. The granting of the Award and the issuance of Performance Units
are subject to the terms and conditions of the Plan, all of which are incorporated into and form an integral part of this Agreement. 
 (b)
The Grantee hereby acknowledges that he or she is to consult with and rely upon only the Grantee’s own tax, legal, and financial advisors regarding the consequences and risks of this Agreement and the award of Performance Units. 

(c) This Agreement may not be amended or modified except by a written agreement executed by the parties hereto or their respective successors
and legal representatives. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect. 
 13.
Counterparts. This Agreement may be executed in counterparts, which together shall constitute one and the same original. 
 [SIGNATURE
PAGE FOLLOWS] 

  
 5 

 IN WITNESS WHEREOF, Cott Corporation has caused this Agreement to be duly executed by one of its duly authorized
officers, and the Grantee has executed this Agreement, effective as of the day and year first above written. 
  

									
	WITNESS:				COTT CORPORATION
					
	By:						By:		  

	  
				Print Name:		 Michael Creamer

	Print Name:		  
				Title:		 VP, Human Resources

				
							GRANTEE:
					
							By:		  

							Print Name:		  

  
 6Exhibit 10.2

 

Loxo Oncology, Inc.

1 Landmark Square, Suite 1122

Stamford, CT 06901

 

March 27, 2015

 

Jennifer Burstein, CPA

 

Re:                             Offer of Employment by Loxo Oncology, Inc.

 

Dear Ms. Burstein:

 

I am very pleased to confirm our offer to you of employment with Loxo Oncology, Inc. (the “Company”).  The terms of our offer and the benefits currently provided by the Company are set forth in this offer letter (this “Offer Letter”) as follows:

 

1.                                      Position.  Your title will be Vice President of Finance, and you will report to the Company’s Chief Executive Officer.  While you render services to the Company, you will not engage in any other employment, consulting or other business activity (whether full-time or part-time) competitive or considered conflicting with the Employer’s business, except as specifically agreed to and with the express written permission of the Chief Executive Officer.

 

2.                                      Starting Salary.  Your starting salary will be $300,000 per year, payable in accordance with the Company’s standard payroll schedule and will be subject to adjustment pursuant to the Company’s employee compensation policies. Your starting date will be May 1, 2015, (the “Start Date”) and shall be considered the initiation date of your employment for the purposes of calculating the anniversary date described below.

 

3.                                      Sign on Bonus.  In connection with your commencement of employment, the Company will pay you a one-time bonus of $20,000, less all applicable withholdings, within thirty (30) days after initiating employment (the “Signing Bonus”).  You agree that should you voluntarily resign from the Company within twelve (12) months of the Start Date, you will repay the full amount of the Signing Bonus to the Company within thirty (30) days of such resignation.

 

4.                                      Management by Objectives Bonus.  You will be eligible for an incentive bonus of up to 30% of your base salary (the “Target Bonus”) for each full fiscal year with the Company following the start of your employment, based on the achievement of individual and Company performance objectives mutually determined in writing by you and the Company’s Chief Executive Officer, in consultation with the Board of Directors (the “Board”) within ninety (90) days after the start of such fiscal year.  For each fiscal year, you will be eligible for an incentive bonus in such amount and upon such terms as shall be determined by the Board. Notwithstanding your commencement of employment with the Company on the Start Date, you will be eligible for your full Target Bonus for the 2015 fiscal year.  Any bonus that you earn for a fiscal year will be paid within 21⁄2 months after the close of that fiscal year, but only if you are still employed by the Company at the time of payment.  The determinations of the Board with respect to your bonus(es) will be final, conclusive and binding.

 

 

5.                                      Benefits.  You will be eligible to participate in regular health insurance, vacation time, bonus and other commonly provided employee benefit plans established by the Company for its employees.

 

6.                                      Travel. You are expected to travel as requested by the Company to complete your job duties. All travel shall be conducted according to the Company’s travel policy and will be subject to the Company’s right to change or otherwise modify, in its sole discretion, the travel requirements set forth in this section. Reimbursable travel and expenses will include travel required beyond the San Francisco Bay area, for example, to company meetings and events in other states or countries.

 

7.                                      Confidentiality.  As an employee of the Company, you will have access to certain confidential information of the Company and you may, during the course of your employment, develop certain information or inventions that will be the property of the Company.  To protect the interests of the Company, you will need to sign the Company’s standard “Employee Invention Assignment and Confidentiality Agreement” as a condition of your employment, a copy of which is attached hereto as Exhibit A.  We wish to impress upon you that we do not want you to, and we hereby direct you not to, bring with you any confidential or proprietary material of any former employer or to violate any other obligations you may have to any former employer.

 

8.                                      No Breach of Obligations to Prior Employers.  You represent that your signing of this Offer Letter, agreement(s) concerning stock options granted to you, if any, under the Plan (as defined below) and the Company’s Employee Invention Assignment and Confidentiality Agreement and your commencement of employment with the Company will not violate any agreement currently in place between yourself and current or past employers.

 

9.                                      Options.  We will recommend to the Board that you be granted an option to purchase up to 50,000 shares of Common Stock of the Company (the “Option”) under our 2014 Equity Incentive Plan (the “Plan”) at the fair market value of the Company’s Common Stock, as determined by the closing price of the Common Stock of the Company on the date the Option is granted.  The Option shares will vest at the rate of 25% at the end of your first anniversary with the Company, and an additional 1/48 of the total Option shares per month thereafter, so long as you remain employed by the Company, as set forth in the applicable stock option agreement.  Stock awards are typically made on an annual basis, and you will be eligible to participate if and when they are made.  All stock awards must be approved by the Board.

 

10.                               Section 16 Obligations.  As the Vice President of Finance and principal financial officer of the Company, you will be deemed an “officer” pursuant to Section 16 of the Securities Exchange Act of 1934 (the “Exchange Act”), and therefore will have certain obligations to report transactions regarding securities of the Company which you are deemed to have beneficial ownership of.  In addition, you will face civil liability if you engage in certain short-term transactions under Section 16(b) of the Exchange Act.

 

11.                               Indemnification.  You and the Company will enter into the form of indemnity agreement provided to other similarly situated executive officers and directors of the Company, in the form attached here as Exhibit B.

 

12.                               At Will Employment.  Should you decide to accept our offer, you will be an at-will employee of the Company, which means the employment relationship can be terminated by

 

 

either of us for any reason, at any time, with or without prior notice and with or without cause.  Any statements or representations to the contrary (and, indeed, any statements contradicting any provision in this letter) should be regarded by you as ineffective.  Further, your participation in any stock option or benefit program is not to be regarded as assuring you of continuing employment for any particular period of time.  Any modification or change in your at will employment status may only occur by way of a written employment agreement signed by you and the Chief Executive Officer of the Company.

 

13.                               Authorization to Work.  Please note that because of employer regulations adopted in the Immigration Reform and Control Act of 1986, within three (3) business days of starting your new position you will need to present documentation demonstrating that you have authorization to work in the United States.  If you have questions about this requirement, which applies to U.S. citizens and non-U.S. citizens alike, you may contact our personnel office.

 

14.                               Arbitration.  You and the Company agree to submit to mandatory binding arbitration any and all claims arising out of or related to your employment with the Company and the termination thereof, including, but not limited to, claims for unpaid wages, wrongful termination, torts, stock or stock options or other ownership interest in the Company, and/or discrimination (including harassment) based upon any federal, state or local ordinance, statute, regulation or constitutional provision.  All arbitration hearings shall be conducted in New York County, New York.  THE PARTIES HEREBY WAIVE ANY RIGHTS THEY MAY HAVE TO TRIAL BY JURY IN REGARD TO SUCH CLAIMS.  This Agreement does not restrict your right to file administrative claims you may bring before any government agency where, as a matter of law, the parties may not restrict the employee’s ability to file such claims (including, but not limited to, the National Labor Relations Board, the Equal Employment Opportunity Commission and the Department of Labor).  However, the parties agree that, to the fullest extent permitted by law, arbitration shall be the exclusive remedy for the subject matter of such administrative claims.  The arbitration shall be conducted through JAMS before a single neutral arbitrator, in accordance with the JAMS employment arbitration rules then in effect. The JAMS rules may be found and reviewed at http://www.jamsadr.com/rules-employment-arbitration. If you are unable to access these rules, please let me know and I will provide you with a hardcopy.  The arbitrator shall issue a written decision that contains the essential findings and conclusions on which the decision is based.

 

15.                               Tax Matters.

 

(a)                                 Withholding.  All forms of compensation referred to in this letter agreement are subject to reduction to reflect applicable withholding and payroll taxes and other deductions required by law.

 

(b)                                 Tax Advice.  You are encouraged to obtain your own tax advice regarding your compensation from the Company.  You agree that the Company does not have a duty to design its compensation policies in a manner that minimizes your tax liabilities, and you will not make any claim against the Company or the Board related to tax liabilities arising from your compensation.

 

16.                               Entire Agreement.  This offer, once accepted, constitutes the entire agreement between you and the Company with respect to the subject matter hereof and supersedes all prior offers, negotiations and agreements, if any, whether written or oral, relating to such subject 

 

 

matter.  You acknowledge that neither the Company nor its agents have made any promise, representation or warranty whatsoever, either express or implied, written or oral, which is not contained in this agreement for the purpose of inducing you to execute the agreement, and you acknowledge that you have executed this agreement in reliance only upon such promises, representations and warranties as are contained herein.

 

17.                               Acceptance.  This offer will remain open through April 3, 2015 If you decide to accept our offer, and I hope you will, please sign the enclosed copy of this Offer Letter and the Employee Invention Assignment and Confidentiality Agreement in the space indicated and return it to me.  Your signature will acknowledge that you have read and understood and agreed to the terms and conditions of this Offer Letter and the attached documents, if any.  Should you have anything else that you wish to discuss, please do not hesitate to call me.

 

We look forward to the opportunity to welcome you to the Company.

 

 

	
 
    	
 
    	
Very truly yours,
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
/s/ Joshua   H. Bilenker
    
	
 
    	
 
    	
Joshua H. Bilenker
    
	
 
    	
 
    	
Chief Executive Officer
    

 

I have read and understood this Offer Letter and hereby acknowledge, accept and agree to the terms as set forth above and further acknowledge that no other commitments were made to me as part of my employment offer except as specifically set forth herein.

 

	
/s/ Jennifer Burstein
    	
 
    	
Date signed:
    	
 
    
	
Jennifer Burstein
    	
 
    	
 
    

 

Attachment: Employee Invention Assignment and Confidentiality Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]